Steward Partners Investment Advisory »

Innate Pharma shares owned by Steward Partners Investment Advisory

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Steward Partners Investment Advisory from 13F filings

Historical chart of Steward Partners Investment Advisory investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Steward Partners Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Steward Partners Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $560 200 2.80
2023-09-30 $1.3k 500 2.53
2023-06-30 $1.5k 500 3.08
2023-03-31 $1.4k 500 2.85
2022-12-31 $1.9k 500 3.73
2022-09-30 $1.0k 500 2.00
2022-06-30 $1.0k 500 2.00
2022-03-31 $2.0k 500 4.00
2021-12-31 $2.0k 500 4.00
2021-09-30 $3.0k 500 6.00
2021-03-31 $2.8k 650 4.31
2020-09-30 $4.0k 1.1k 3.64
2020-06-30 $8.0k 1.1k 7.27
2020-03-31 $7.0k 1.1k 6.36
2019-12-31 $7.0k 1.1k 6.36

More positions owned by Steward Partners Investment Advisory

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
UnitedHealth (UNH)
Ishares Tr Rus 1000 Grw Etf (IWF)
Home Depot (HD)
Tesla Motors (TSLA)

View all positions for Steward Partners Investment Advisory

Top funds holding Innate Pharma

Exchange Traded Concepts
Millennium Management
Barclays
Rhumbline Advisers
Steward Partners Investment Advisory
UBS Group

View all funds holding Innate Pharma